Poster #128

Real-world study of vedolizumab-treated pediatric patients with inflammatory bowel disease using data from the ImproveCareNow Registry

Marfatia S, Swallow E, Lax A, Velazco N, Stylopoulos N, Farhat Z (presenting author), Saeed SA

Poster Session I

Thursday, October 22, 2026

5:00-7:00 PM

Marriott Marquis, Pacific Ballroom

Poster #133

Identifying clinical gaps and educational opportunities in the diagnosis and management of pediatric inflammatory bowel disease: A needs assessment

Gold BD (presenting author), Barfield E, Wojtowicz AM, Schwind A, Coleman B, Salinas G

Poster Session I

Thursday, October 22, 2026

5:00-7:00 PM

Marriott Marquis, Pacific Ballroom

Poster #134

Long-term safety of intravenous vedolizumab in paediatric patients with moderate-to-severe ulcerative colitis in two open-label extension studies

Hyams J, Gorla K (presenting author), Kierkus J, Szakos E, Korczowski B, Strisciuglio C, Chen J, Takaki Y, Tran VA, Durairaj C, Rizvi A, Castriota F, Velazco N, Stylopoulos N, Hoffman I

Poster Session I

Thursday, October 22, 2026

5:00-7:00 PM

Marriott Marquis, Pacific Ballroom

Poster #135

Efficacy and safety of intravenous vedolizumab in pediatric patients with moderate-to-severe ulcerative colitis: Results from the Kepler Phase 3 Trial

Turner D, Kierkus J, Korczowski B, Strisciuglio C, Chen J, Takaki Y, Szakos E, Arumugam R, Gorla K (presenting author), Rizvi A, Yoon M, Campagne O, Angellotti E, Velazco N, Candela N

Poster Session I

Thursday, October 22, 2026

5:00-7:00 PM

Marriott Marquis, Pacific Ballroom

Poster #454

Real-world growth outcomes in pediatric patients with Crohn’s disease or ulcerative colitis treated with vedolizumab: An ImproveCareNow Registry Study

Runde J (presenting author), Hoffman JM, Dekaney C, Lax A, Wang T, Swallow E, Mu F, Reichert E, Young LE, Null K, Saeed S

Poster Session II

Friday, October 23, 2026

12:00-2:00 PM

Marriott Marquis, Pacific Ballroom

Poster #809

Economic burden, economic evaluations, healthcare resource utilization, and utilities reported in pediatric patients with moderate-to-severe ulcerative colitis and Crohn’s disease: A systematic literature review

Farhat Z (presenting author), von Wilamowitz-Moellendorf C, Bhagat A, Pathak S, Mandlik R, Stylopoulos N, Nucit A, Langer J, Karki C

Poster Session III

Saturday, October 24, 2026

12:00-2:00 PM

Marriott Marquis, Pacific Ballroom

Poster #816

Clinical efficacy/effectiveness, safety, and quality of life of pediatric patients with ulcerative colitis and Crohn’s disease treated with immunotherapy biological and small molecule agents: A systematic literature review

Farhat Z (presenting author), von Wilamowitz-Moellendorf C, Bhagat A, Pathak S, Mandlik R, Stylopoulos N, Nucit A, Langer J, Karki C

Poster Session III

Saturday, October 24, 2026

12:00-2:00 PM

Marriott Marquis, Pacific Ballroom